智通财经APP获悉，瑞银发布研报称，瑞银予京东健康(06618)目标价78港元，评级“买入”。京东健康公布截至去年12月底止全年业绩，收入734亿元人民币（下同），年增26.3%；调整后净利润65亿元。收入和盈利均胜预期。瑞银表示，集团2025年收入增长超越22%至25%的指引范围；调整后营业利润率同比增1.5个百分点（主要来自毛利率年增1.9个百分点）；调整后净利润超越62亿至63亿元的指引。去年末季收入同比增27.4%，认为主要来自季节性流感需求，而投资者应关注2026年指引。
智通财经APP获悉，瑞银发布研报称，瑞银予京东健康(06618)目标价78港元，评级“买入”。京东健康公布截至去年12月底止全年业绩，收入734亿元人民币（下同），年增26.3%；调整后净利润65亿元。收入和盈利均胜预期。瑞银表示，集团2025年收入增长超越22%至25%的指引范围；调整后营业利润率同比增1.5个百分点（主要来自毛利率年增1.9个百分点）；调整后净利润超越62亿至63亿元的指引。去年末季收入同比增27.4%，认为主要来自季节性流感需求，而投资者应关注2026年指引。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.